20 March 2020
We respond to reports about the use of ibuprofen and anti-inflammatory medicines in the treatment of COVID-19.
18 March 2020
The overall rates of smoking among UK adults and young people have declined in recent decades. Legislation around the consumption, sale and advertisement of cigarettes has become tighter, and wide-reaching public health campaigns have taken effect.
7 March 2020
A good start in life is critical for health—and this story begins before birth. The WHO states that monitoring maternal and child health during pregnancy is critical, and that smoking is one of the most important modifiable lifestyle choices during this period.
4 March 2020
The RCPCH has today published State of Child Health 2020, the largest ever compilation of data on the health of babies, children and young people across all four UK nations. The report shows that for many measures of children’s health and wellbeing, progress has stalled, or is in reverse – something...
25 February 2020
Dr Judith Van der Voort discusses what we’re doing to support your future working lives as part of our ambitious Paediatrics 2040 project.
19 February 2020
Dr Nicola Jay discusses why and how we are thinking about future paediatric models of care as part of our ambitious Paediatrics 2040 project.
12 February 2020
Dr Damian Roland explains why innovation is one of the four major workstreams we are considering in our Paediatrics 2040 project.
5 February 2020
Dr Mike Linney, Registrar and Chair of the Ethics Committee for RCPCH, welcomes recent guidance from NICE, but notes the urgent need for high quality, independent research on this medicine to provide the best possible care for children with complex epilepsy.
4 February 2020
Professor Steve Turner shares an update on the data and evidence activity that’s underway to support our Paediatrics 2040 project.
3 February 2020
NHSE is conducting a review of the specification for this service and associated policies for 2020. It will also set up an independent expert group to make recommendations regarding the use of puberty suppressants and cross-sex hormones.